Co-isolates of Acinetobacter baumannii complex in polymicrobial infections: a meta-analysis

2022-05-10

Our latest research was just published in Access Microbiology (Microbiology Society), May 2022.

Co-isolates of Acinetobacter baumannii complex in polymicrobial infections: a meta-analysis.

Karakonstantis S, Ioannou P, and Kritsotakis EI.

Access via:

Publisher site
PubMed Central (PMC)

Co-isolates of Acinetobacter baumannii complex in polymicrobial infections: a meta-analysis.

Abstract

Background. Acinetobacter baumannii complex (ABC) infections are commonly polymicrobial. Examining which pathogens are most commonly co-isolated with ABC is an important first step for assessing disease potential due to pathogen-pathogen interactions.

Methods. Based on a systematic search of PubMed, Scopus and CENTRAL, we estimated percent proportions of co-isolates in polymicrobial pulmonary and bloodstream ABC infections using random-effects meta-analysis.

Results. Twenty-eight eligible studies were analysed reporting 575 polymicrobial bloodstream and 290 polymicrobial pulmonary infections. Common co-isolates in pulmonary infections were P. aeruginosa (36%, 95% CI 24-49%, I2 71%), S. aureus (28%, 95% CI 19-38%, I2 44%) and Klebsiella spp. (11%, 95% CI 6-20 %, I2 56%), while the prevalence of other co-pathogens did not exceed 5%. Most common co-isolates in bloodstream infections were coagulase-negative Staphylococci (21%, 95% CI 12-34 %, I2 84%), Enterococci (15%, 95% CI 9-26%, I2 73%), P. aeruginosa (12%, 95% CI 6-22%, I2 74%), Klebsiella spp. (10%, 95% CI 6-16%, I2 42%), Enterobacter spp. (10%, 95% CI 6-16 %, I2 38%) and S. aureus (8%, 95% CI 4-15%, I2 58%).

Conclusion. The common co-isolation of certain pathogens (especially P. aeruginosa) with ABC suggests potential beneficial between-pathogen interactions, which may have treatment implications for polymicrobial infections and requires further study.

Keywords. Acinetobacter, polymicrobial, Pseudomonas, pneumonia, bacteremia